Edition:
United States

Eiger BioPharmaceuticals Inc (EIGR.OQ)

EIGR.OQ on NASDAQ Stock Exchange Global Market

11.89USD
19 Oct 2018
Change (% chg)

$-0.13 (-1.08%)
Prev Close
$12.02
Open
$12.10
Day's High
$12.10
Day's Low
$11.71
Volume
46,021
Avg. Vol
19,970
52-wk High
$18.00
52-wk Low
$7.50

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Jun '18 0.00 -0.823
Mar '18 0.00 -0.839
FY 2017 Dec '17 0.00 -1.110
Sep '17 0.00 -1.095
Jun '17 0.00 -1.332
Mar '17 0.00 -1.344
FY 2016 Dec '16 0.00 -1.525
Sep '16 0.00 -1.492
Jun '16 0.00 -1.867
Mar '16 0.00 -10.418
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Dec-18 5 0.00 0.00 0.00 0.00
Quarter Ending Mar-19 3 0.00 0.00 0.00 --
Year Ending Dec-18 6 0.00 0.00 0.00 3.33
Year Ending Dec-19 7 8.92 50.00 0.00 9.78
Earnings (per share)
Quarter Ending Dec-18 6 -0.70 -0.53 -0.86 -1.41
Quarter Ending Mar-19 4 -0.78 -0.61 -0.92 -1.46
Year Ending Dec-18 6 -3.01 -2.71 -3.35 -4.94
Year Ending Dec-19 7 -2.59 0.35 -3.82 -4.65
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 85.68 33.65
P/E High - Last 5 Yrs. -- 288.23 45.13
P/E Low - Last 5 Yrs. -- 90.01 23.75
Beta 2.57 0.93 0.88
Price to Sales (TTM) -- 123.57 5.82
Price to Book (MRQ) 5.20 15.30 4.89
Price to Tangible Book (MRQ) 5.20 14.52 6.51
Price to Cash Flow (TTM) -- 70.32 22.93
% Owned Institutions 68.95 14.11 2.13

Dividends

  Company industry sector
Dividend Yield -- 0.33 1.51
Dividend Yield - 5 Year Avg -- 0.24 1.52
Dividend 5 Year Growth Rate -- 2.55 5.40
Payout Ratio(TTM) -- 16.80 43.86

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -- 412.64 8.09
Sales (TTM) vs TTM 1 Yr. Ago -- 103.64 5.80
Sales - 5 Yr. Growth Rate -- 30.76 9.87
EPS (MRQ) vs Qtr. 1 Yr. Ago 28.66 24.21 23.78
EPS (TTM) vs TTM 1 Yr. Ago 89.21 -- --
EPS - 5 Yr. Growth Rate -- 37.74 10.93
Capital Spending - 5 Yr. Growth Rate -- 38.54 14.87

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 1.94 2.25
Current Ratio (MRQ) 7.01 5.34 3.05
LT Debt to Equity (MRQ) 72.07 34.98 12.75
Total Debt to Equity (MRQ) 72.07 36.79 17.17
Interest Coverage (TTM) -30.39 -97.05 37.51

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 40.12 54.87
Gross Margin - 5 Yr. Avg. -- 49.12 52.39
EBITD Margin (TTM) -- -- --
EBITD - 5 Yr. Avg -- -579.55 11.02
Operating Margin (TTM) -- -771.33 4.30
Operating Margin - 5 Yr. Avg. -- -600.70 6.36
Pre-Tax Margin (TTM) -- -733.55 5.35
Pre-Tax Margin - 5 Yr. Avg. -- -606.33 6.80
Net Profit Margin (TTM) -- -734.48 1.62
Net Profit Margin - 5 Yr. Avg. -- -609.01 3.04
Effective Tax Rate (TTM) -- 23.59 23.24
Effective Tax Rate - 5 Yr. Avg. -- 18.75 24.16

Efficiency

  Company industry sector
Revenue/Employee (TTM) 0 22,746,690 808,425,748
Net Income/Employee (TTM) -2,326,150 1,711,865 95,083,073
Receivable Turnover (TTM) -- 19.81 5.77
Inventory Turnover (TTM) -- 2.38 3.63
Asset Turnover (TTM) 0.00 0.40 0.92

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -105.46 -1.19 10.91
Return on Assets - 5 Yr. Avg. -53.65 3.14 12.01
Return on Investment (TTM) -116.96 0.45 14.28
Return on Investment - 5 Yr. Avg. -67.98 2.23 15.61
Return on Equity (TTM) -143.95 1.37 16.00
Return on Equity - 5 Yr. Avg. -- 2.97 16.87
  1 Year 3 Year 5 Year
Sales % -- -- --
EPS (TTM) % 87.39 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Eiger BioPharmaceuticals Inc

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 79.63%
# of Holders: 74
Total Shares Held: 11,342,847
3 Mo. Net Change: 582,052
# New Positions: 1
# Closed Positions: 3
# Increased Positions: 3
# Reduced Positions: 4
# Net Buyers: -1
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.